CompletedNot Applicable

Total Placenta Previa Associated With the Placenta Accreta Spectrum.

Turkey (Türkiye)277 participantsStarted 2017-11-01

Plain-language summary

To assess the reliability of placental magnetic resonance imaging measurements in predicting peripartum hysterectomy and neonatal outcomes in patients with total placenta previa.

Who can participate

Age range

17 Years – 42 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 27th to 37th weeks of gestation * Third trimester of pregnancy * Pregnants had received a t-PP diagnosis via color Doppler ultrasonography (cd-USG) and/or placental MRI (p-MRI). * All singleton pregnancies in which t-PP extended to both the anterior and posterior uterine walls, resulting in complete coverage of the internal cervical os by the placenta Exclusion Criteria: * Any cases of low-lying/marginal placenta previa * Preoperative hemoglobin level \< 9 g/dL * Pregnant women with coagulation disorders * Morbid obesity * Multiple fetal pregnancies * Individuals delivered before \< 27 weeks of gestation

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Assessment of risk factors affecting peripartum hysterectomy in placenta previa patients undergoing without MRI screening

Timeframe: Assessed during the peripartum period, within the first two days postpartum.

Clinical risk factors affecting p-TAH in patients with t-PP undergoing p-MRI.

Timeframe: Assessed during the peripartum period, within the first 2 days postpartum.

Identification of risk factors affecting neonatal mortality regardless of whether MRI scanning is used.

Timeframe: Assessed at the time of delivery.

Trial details

NCT IDNCT06219564

SponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-21

View on ClinicalTrials.gov More Maternal; Procedure trials